149 related articles for article (PubMed ID: 7502870)
1. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea.
Svennerholm AM; Holmgren J
Adv Exp Med Biol; 1995; 371B():1623-8. PubMed ID: 7502870
[No Abstract] [Full Text] [Related]
2. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization against cholera.
Holmgren J; Clemens J; Sack DA; Sanchez J; Svennerholm AM
Curr Top Microbiol Immunol; 1989; 146():197-204. PubMed ID: 2659268
[No Abstract] [Full Text] [Related]
4. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
5. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
6. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
7. Cholera as a model for research on mucosal immunity and development of oral vaccines.
Holmgren J; Czerkinsky C
Curr Opin Immunol; 1992 Aug; 4(4):387-91. PubMed ID: 1388838
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
Ruan X; Zhang W
Vaccine; 2013 Mar; 31(11):1458-63. PubMed ID: 23375979
[TBL] [Abstract][Full Text] [Related]
9. The antibody response in infants after oral administration of inactivated and living E. coli vaccines and their protective effect against nosocomial infections.
Lodinová-Zádníková R; Tlaskalová H; Korych B; Bartáková Z
Adv Exp Med Biol; 1995; 371B():1431-8. PubMed ID: 7502832
[No Abstract] [Full Text] [Related]
10. Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.
Wennerås C; Czerkinsky C; Svennerholm AM
Adv Exp Med Biol; 1995; 371B():1641-4. PubMed ID: 7502873
[No Abstract] [Full Text] [Related]
11. Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.
Holmgren J; Svennerholm AM
Scand J Infect Dis Suppl; 1990; 76():47-53. PubMed ID: 2102020
[TBL] [Abstract][Full Text] [Related]
12. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
Evans DG; Graham DY; Evans DJ
Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
[TBL] [Abstract][Full Text] [Related]
13. New vaccines against bacterial enteric infections.
Holmgren J; Svennerholm AM
Scand J Infect Dis Suppl; 1990; 70():149-56. PubMed ID: 2287897
[TBL] [Abstract][Full Text] [Related]
14. Recombinant DNA technology and enterotoxigenic Escherichia coli vaccines.
Gyles CL; Maas WK
Prog Vet Microbiol Immunol; 1987; 3():139-58. PubMed ID: 3078832
[No Abstract] [Full Text] [Related]
15. Statement on new oral cholera and travellers' diarrhea vaccination.
;
Can Commun Dis Rep; 2005 Jul; 31(ACS-7):1-11. PubMed ID: 15999424
[No Abstract] [Full Text] [Related]
16. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
[TBL] [Abstract][Full Text] [Related]
17. Enteric vaccines for resource-limited countries: current status and future prospects.
Desai SN; Sahastrabuddhe S; Ochiai RL; Wierzba TF
Pediatr Ann; 2011 Jul; 40(7):351-7. PubMed ID: 21736257
[No Abstract] [Full Text] [Related]
18. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
[TBL] [Abstract][Full Text] [Related]
19. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
20. Preliminary conjoint statement on oral cholera vaccination.
CMAJ; 1996 Oct; 155(8):1087-90. PubMed ID: 8873638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
